SciTech Development, LLC   Report issue

For profit Phase 1 Phase 2
Founded: Grosse Pointe Farms MI United States (2001)

Organization Overview

First Clinical Trial
2020
NCT04234048
First Marketed Drug
2022
abiraterone (zytiga)
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Beijing Scitech-Mq Pharmaceuticals Limited | NOVUGEN | SciTech Development, LLC